Cabaletta Bio Stock Analysis

Cabaletta Stock Analysis Notes

About 72.0% of the company shares are held by institutions such as insurance companies. The book value of Cabaletta Bio was currently reported as 3.86. The company recorded a loss per share of 1.7. Cabaletta Bio had not issued any dividends in recent years. Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Cabaletta Bio, Inc. was incorporated in 2017 and is headquartered in Philadelphia, Pennsylvania. Cabaletta Bio operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 57 people. For more info on Cabaletta Bio please contact the company at 267 759-3100 or go to www.cabalettabio.com.

Cabaletta Bio Investment Alerts

Cabaletta Bio Upcoming and Recent Events

Cabaletta Largest EPS Surprises

View All Earnings Estimates

Cabaletta Bio SEC Filings

Cabaletta Stock Institutional Investors

Note, although Cabaletta Bio's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Cabaletta Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 686.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Cabaletta Bio's market, we take the total number of its shares issued and multiply it by Cabaletta Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Cabaletta Profitablity

Management Efficiency

Cabaletta Bio has return on total asset (ROA) of (0.3199) % which means that it has lost $0.3199 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.5063) %, meaning that it created substantial loss on money invested by shareholders. Cabaletta Bio's management efficiency ratios could be used to measure how well Cabaletta Bio manages its routine affairs as well as how well it operates its assets and liabilities. As of December 3, 2023, Return on Average Assets is expected to decline to -0.54. In addition to that, Return on Average Equity is expected to decline to -0.55. At present, Cabaletta Bio's Total Assets are projected to increase significantly based on the last few years of reporting. The current year's Current Assets is expected to grow to about 117.7 M, whereas Return on Average Assets are forecasted to decline to (0.54).

Technical Drivers

As of the 3rd of December, Cabaletta Bio shows the risk adjusted performance of 0.0552, and Mean Deviation of 3.97. Cabaletta Bio technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyzed nineteen technical drivers for Cabaletta Bio, which can be compared to its rivals. Please confirm Cabaletta Bio mean deviation, standard deviation, treynor ratio, as well as the relationship between the downside deviation and information ratio to decide if Cabaletta Bio is priced correctly, providing market reflects its regular price of 16.02 per share. Given that Cabaletta Bio has jensen alpha of 0.3371, we suggest you to validate Cabaletta Bio's prevailing market performance to make sure the company can sustain itself at a future point.

Cabaletta Bio Price Movement Analysis

Cabaletta Bio Insider Trading Activities

Cabaletta Bio Technical and Predictive Indicators

Cabaletta Bio Forecast Models

Cabaletta Bio's time-series forecasting models are one of many Cabaletta Bio's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Cabaletta Bio's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Cabaletta Bio prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Cabaletta shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Cabaletta Bio. By using and applying Cabaletta Stock analysis, traders can create a robust methodology for identifying Cabaletta entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Cabaletta analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Cabaletta analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Cabaletta Bio stock analysis indicators help investors evaluate how Cabaletta Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Cabaletta Bio shares will generate the highest return on investment. By understating and applying Cabaletta Bio stock analysis, traders can identify Cabaletta Bio position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cabaletta Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in bureau of labor statistics. For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.Note that the Cabaletta Bio information on this page should be used as a complementary analysis to other Cabaletta Bio's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.

Is Cabaletta Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.